LeafNLP Demos
Back to explore

Report #2888300

Received Mar 10, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
UT
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
MNQMENINGOCOCCAL CONJUGATE (MENVEO)NOVARTIS VACCINES AND DIAGNOSTICSUNKUNK—
TDAPTDAP (BOOSTRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (1)

Product storage error

Symptom narrative

MENVEO and BOOSTRIX after they have suffered a Temperature Excursion; This non-serious case was reported by a other health professional via other manufacturer and described the occurrence of incorrect storage of drug in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis. On an unknown date, the patient received Menveo and Boostrix. On an unknown date, an unknown time after receiving Menveo and Boostrix, the patient experienced incorrect storage of drug (Verbatim: MENVEO and BOOSTRIX after they have suffered a Temperature Excursion). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-MAR-2026 The healthcare professional reported that the patient might have received Menveo and Boostrix after they suffered a Temperature Excursion. The batch number was not provided and request for this information has been made.